Advent Life Sciences

Contacts: Skipped - triage

Description

Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and investment success through turning break-through science into approved medicines or medical products. We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines. As entrepreneurs and experienced, pragmatic investors, we bring the intellectual capital of our well connected team to support each investment. We work in close alignment with our management teams, and partner with them to realise their vision - achieving superior financial returns by bringing innovation to patients. The companies in which we have invested since the year 2000 have discovered and developed, fourteen approved medicines and products - to the benefit of patients, physicians and our investors.

Location

United Kingdom

Industry

Venture Capital and Private Equity Principals

Investor Type

Private Equity

Target Sectors

Verticals

No verticals classified

Specialities

Venture Capital, Life Sciences, Innovation, Medtech, Drug Discovery, Investment, First in class, Best in class, Small molecules, Biologics, New modalities, Healthcare, Drug Development, Science, Medicine, TranslationalScience

Financials

Revenue

EBITDA

Employees

25

Founded

2005

Classify Status

Triage: pure_vc — Transatlantic life sciences early-stage VC

Prospects

0 people

No prospects linked to this account.

Outreach History

Outreach sequencing tables are not yet in Supabase.

ID: 13619Airtable: vayne-100577-117Created: 10/06/2026